Ovid Therapeutics Plans to Move into the Phase 3 Trial Based on End-of-Phase 2 Meeting for OV101 Pharmaceutical Investing
VBI Vaccines Enters into License and Collaboration Agreement with Brii Biosciences Pharmaceutical Investing
Green Growth Brands Solidifies Nevada Market Position with Award of Seven Additional Cannabis Licenses Cannabis Investing News
BriaCell Presents Positive Efficacy Data with Lead Cancer Drug Candidate in Phase IIa Monotherapy and Excellent Initial Safety Data in Combination with KEYTRUDA® at a Major Breast Cancer Conference Biotech Investing
Orchard Therapeutics Scientific Advisory Board Member Presents Clinical Proof-of-Concept Data Biotech Investing
Naturally Splendid Appoints Compounding Pharmacist, Bob Mehr, to Advisory Board for NateraFX™ Cannabis Investing News
Canntab Enters Into a Binding Term Sheet With Leading Orthopaedic Surgeon Dr. Don Garbuz, M.D. for a Clinical Research Trial of Canntab’s Tablets Cannabis Investing News
